TAK-259 HCl - CAS 1192347-42-4

TAK-259 is a novel, selective, and orally active α1D adrenergic receptor antagonist (α1D, Ki = 1.1 nM) that represents a promising new therapeutic agent for the treatment of symptoms of OAB. It has an anti-frequency effect and reduces the burden of the human Ether-a-Go-Go-Related gene (HERG) .

Others

Others

1192301

C14H14Cl3N3O3S

410.7

Cl.O=C(N)C1=CC(Cl)=CN(C1=N)CC2=CC(Cl)=CC=C2S(=O)(=O)C

-20°C

Ice Packs

Small Compound